Literature DB >> 16779059

Using Bayesian networks to predict survival of liver transplant patients.

Nathan Hoot1, Dominik Aronsky.   

Abstract

The relative scarcity of grafts available for liver transplantation highlights the need to identify patients likely to have good outcomes after treatment. We used transplant information from the United Network for Organ Sharing database to construct a Bayesian network model to predict 90-day graft survival. The final model incorporated a set of 29 pre-transplant variables, and it achieved performance, as measured by area under the receiver operating characteristic curve, of 0.674 by cross-validation and 0.681 on an independent validation set. The results showed a positive predictive value of 91%, while the negative predictive value was lower at 30%. With additional refinement and validation, our model may be useful as an adjunct to clinical experience in identifying patients most likely to have good outcomes following liver transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 16779059      PMCID: PMC1560677     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  14 in total

1.  Recurrent neural networks for predicting outcomes after liver transplantation: representing temporal sequence of clinical observations.

Authors:  B Parmanto; H R Doyle
Journal:  Methods Inf Med       Date:  2001       Impact factor: 2.176

2.  Organ Procurement and Transplantation Network--HRSA. Final rule with comment period.

Authors: 
Journal:  Fed Regist       Date:  1998-04-02

3.  A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics.

Authors:  Paul J Thuluvath; Hwan Y Yoo; Richard E Thompson
Journal:  Liver Transpl       Date:  2003-05       Impact factor: 5.799

4.  Operative parameters that predict the outcomes of hepatic transplantation.

Authors:  James F Markmann; Joseph W Markmann; Niraj M Desai; Angeles Baquerizo; Jennifer Singer; Hasan Yersiz; Curtis Holt; Rafik M Ghobrial; Douglas G Farmer; Ronald W Busuttil
Journal:  J Am Coll Surg       Date:  2003-04       Impact factor: 6.113

5.  Toward normative expert systems: Part I. The Pathfinder project.

Authors:  D E Heckerman; E J Horvitz; B N Nathwani
Journal:  Methods Inf Med       Date:  1992-06       Impact factor: 2.176

6.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

7.  Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants.

Authors:  J F Markmann; J W Markmann; D A Markmann; A Bacquerizo; J Singer; C D Holt; J Gornbein; H Yersiz; M Morrissey; S M Lerner; S V McDiarmid; R W Busuttil
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

8.  Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.

Authors:  Niraj M Desai; Kevin C Mange; Michael D Crawford; Peter L Abt; Adam M Frank; Joseph W Markmann; Ergun Velidedeoglu; William C Chapman; James F Markmann
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

9.  Predictive factors for early mortality following liver transplantation.

Authors:  Itxarone Bilbao; Luis Armadans; Jose L Lazaro; Ernest Hidalgo; Luis Castells; Carlos Margarit
Journal:  Clin Transplant       Date:  2003-10       Impact factor: 2.863

10.  Pretransplant model to predict posttransplant survival in liver transplant patients.

Authors:  Rafik M Ghobrial; Jeffery Gornbein; Randy Steadman; Natale Danino; James F Markmann; Curtis Holt; Dean Anselmo; Farin Amersi; Pauline Chen; Douglas G Farmer; Steve Han; Francisco Derazo; Sammy Saab; Leonard I Goldstein; Sue V McDiarmid; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  7 in total

1.  A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality.

Authors:  Natasha A Loghmanpour; Manreet K Kanwar; Marek J Druzdzel; Raymond L Benza; Srinivas Murali; James F Antaki
Journal:  ASAIO J       Date:  2015 May-Jun       Impact factor: 2.872

2.  Physician predictions of graft survival following liver transplantation.

Authors:  Nathan R Hoot; Irene D Feurer; Mary T Austin; Michael K Porayko; J Kelly Wright; Nancy M Lorenzi; C Wright Pinson; Dominik Aronsky
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  An Approach for Incorporating Context in Building Probabilistic Predictive Models.

Authors:  Juan Anna Wu; William Hsu; Alex At Bui
Journal:  Proc IEEE Int Conf Healthc Inform Imaging Syst Biol       Date:  2012-12-03

4.  Development of a Bayesian model to estimate health care outcomes in the severely wounded.

Authors:  Alexander Stojadinovic; John Eberhardt; Trevor S Brown; Jason S Hawksworth; Frederick Gage; Douglas K Tadaki; Jonathan A Forsberg; Thomas A Davis; Benjamin K Potter; James R Dunne; E A Elster
Journal:  J Multidiscip Healthc       Date:  2010-08-16

5.  Development of a clinical decision model for thyroid nodules.

Authors:  Alexander Stojadinovic; George E Peoples; Steven K Libutti; Leonard R Henry; John Eberhardt; Robin S Howard; David Gur; Eric A Elster; Aviram Nissan
Journal:  BMC Surg       Date:  2009-08-10       Impact factor: 2.102

6.  Cardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy.

Authors:  Natasha A Loghmanpour; Marek J Druzdzel; James F Antaki
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

7.  A molecular computational model improves the preoperative diagnosis of thyroid nodules.

Authors:  Sara Tomei; Ivo Marchetti; Katia Zavaglia; Francesca Lessi; Alessandro Apollo; Paolo Aretini; Giancarlo Di Coscio; Generoso Bevilacqua; Chiara Mazzanti
Journal:  BMC Cancer       Date:  2012-09-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.